Literature DB >> 28768264

Pathological Concordance between Prostate Biopsies and Radical Prostatectomy Using Transperineal Sector Mapping Biopsies: Validation and Comparison with Transrectal Biopsies.

Giancarlo Marra1, David Eldred-Evans, Ben Challacombe, Mieke Van Hemelrijck, Alexander Polson, Sabine Pomplun, Christopher S Foster, Christian Brown, Declan Cahill, Paolo Gontero, Rick Popert, Gordon Muir.   

Abstract

Background/Aims/
Objectives: Our aim was to evaluate the accuracy of systematic transperineal sector mapping biopsy (TPSMB) in predicting Gleason score (GS) at radical prostatectomy (RP), to compare its accuracy with standard transrectal ultrasound-guided biopsies (TRUS) and to establish the clinical impact of discordance between biopsies and RP on subsequent surgical management.
METHODS: Two hundred fifty-five patients from 2008 to 2013 who underwent RP following TPSMB (n = 204) or TRUS (n = 51), were included in this retrospective multi-institutional study. Concordance between biopsies and RPs GS was assessed both as percentages and with Cohen's Kappa coefficient. All mismatches between biopsies and RP were assessed for significance by 3 urologists using the Delphi method.
RESULTS: No differences were present among the groups. Concordance between biopsy and RP GS was 75.49% for TPSMB and 64.70% for TRUS. Kappa coefficient was 0.42 and 0.39 respectively. The Delphi method showed lower clinical impact of GS discordances for TPSMB with 7.8% of patients having significant change, thus being potentially more suitable for other treatment modalities, compared to TRUS (13.7%).
CONCLUSIONS: TPSMB had a higher accuracy for predicting the GS grade at RP showing superior GS concordance compared with standard TRUS. TPSMB provides an effective technique for systematic prostate biopsy to evaluate overall prostate cancer GS.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Diagnosis; Gleason score; Prostate biopsy; Prostate cancer ; Radical prostatectomy; Transperineal biopsy; Transperineal template biopsy; Transrectal biopsy

Mesh:

Year:  2017        PMID: 28768264     DOI: 10.1159/000471491

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  6 in total

1.  Gleason grade accuracy of transperineal and transrectal prostate biopsies in MRI-naïve patients.

Authors:  Liang G Qu; Modher Al-Shawi; Tess Howard; Nathan Papa; Cedric Poyet; Brian Kelly; A J Matthew Egan; Nathan Lawrentschuk; Damien Bolton; Gregory S Jack
Journal:  Int Urol Nephrol       Date:  2021-10-08       Impact factor: 2.370

2.  Impact of delay from transperineal biopsy to radical prostatectomy upon objective measures of cancer control.

Authors:  Liang G Qu; Gregory Jack; Marlon Perera; Melanie Evans; Sue Evans; Damien Bolton; Nathan Papa
Journal:  Asian J Urol       Date:  2021-09-06

3.  Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings.

Authors:  Kerri Beckmann; Michael O'Callaghan; Andrew Vincent; Penelope Cohen; Martin Borg; David Roder; Sue Evans; Jeremy Millar; Kim Moretti
Journal:  Asian J Urol       Date:  2019-03-07

4.  Development and internal validation of a prediction model of prostate cancer on initial transperineal template-guided prostate biopsy.

Authors:  Yuliang Chen; Zhien Zhou; Yi Zhou; Xingcheng Wu; Yu Xiao; Zhigang Ji; Hanzhong Li; Weigang Yan
Journal:  BMC Urol       Date:  2021-04-23       Impact factor: 2.264

5.  Rebiopsy rate after transperineal or transrectal prostate biopsy.

Authors:  Jose L Marenco Jimenez; Francesco Claps; Juan C Ramón-Borja; Juan M Mascarós Martinez; Augusto W Gutierrez; Álvaro G F Lozano; Miguel Ramírez-Backhaus; Jose L Domìnguez Escrig; Argimiro C Serra; Jose Rubio-Briones
Journal:  Prostate Int       Date:  2020-10-17

6.  Magnetic resonance imaging /ultrasonography fusion transperineal prostate biopsy for prostate cancer: Initial experience at a Middle Eastern tertiary medical centre.

Authors:  Adnan El-Achkar; Mouhammad Al-Mousawy; Nassib Abou Heidar; Hisham Moukaddem; Hero Hussein; Nadim Mouallem; Albert El-Hajj; Muhammad Bulbul
Journal:  Arab J Urol       Date:  2021-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.